Karman Stock: A Buy After 40% Drop and Strong Earnings?
💡 Key Takeaway
Karman's recent 40% price drop, combined with record Q1 earnings, a $1 billion backlog, and raised guidance, presents a more attractive entry point for long-term growth investors.
What Happened to Karman Stock?
Defense contractor Karman had a wild ride since its 2025 IPO. After pricing at $22, the stock soared over 230% to end 2025 near $73, outperforming peers like Kratos Defense and Rocket Lab. The rally continued into early 2026, pushing shares to an all-time high near $115, which valued the company at a sky-high forward P/E ratio above 200x.
Since that peak, the stock has corrected sharply, falling more than 40%. This pullback has cut its forward P/E ratio roughly in half, making the valuation much less extreme than before.
The company's Q1 2026 earnings provided a fundamental reason for optimism. Karman reported record quarterly revenue of $151.2 million, a 51% year-over-year jump that slightly beat estimates. Adjusted earnings per share more than doubled to $0.11, handily beating expectations.
Adding to the positive news, Karman raised its full-year 2026 sales and adjusted EBITDA guidance for the second consecutive quarter. The company also saw strong growth across all its key defense segments and introduced a new Maritime Defense Systems segment from a recent acquisition.
What This Means for Me
Why This News Matters for Investors
For investors, the core story is about valuation meeting execution. The steep drop in share price has brought Karman's premium valuation down to a more reasonable, though still high, level of around 109x forward earnings. This is below its historical average since going public.
The company's fundamentals are strengthening. A $1 billion backlog, up 61% year-over-year, provides high visibility into future revenue, covering about 1.4 times its 2026 sales forecast. Management also has 90% visibility into this year's revenue target, significantly de-risking the near-term outlook.
Beyond the backlog, Karman has secured contingent demand commitments with a potential value over $1 billion, which could fuel growth for years if its customers win government contracts. This positions the company in high-growth areas like hypersonics and space.
Leadership changes can be risky, but the transition to new CEO Jon Rambeau, a 30-year defense industry veteran from L3Harris and Lockheed Martin, appears smooth given the company's current strong performance. Wall Street analysts remain bullish, with a consensus price target near $115 implying over 65% upside from current levels.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| KRMN | Positive | Strong Q1 earnings beat, raised guidance, a massive $1B backlog, and a significant price correction have improved the risk/reward profile for this high-growth defense stock. | |
| KTOS | Neutral | As a peer mentioned for its strong 2025 performance, Kratos may see sentiment influenced by sector trends, but no company-specific news was provided. | |
| RKLB | Neutral | Mentioned alongside Karman as a top 2025 performer in the defense/aerospace sector, but the article contains no new analysis on Rocket Lab's current outlook. |
Source: Investing.com
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Karman's post-correction valuation now presents a compelling opportunity for investors comfortable with high-growth, higher-risk names.
The company is executing brilliantly with rapid growth and soaring profitability, while key risk indicators like its massive backlog and revenue visibility are strong. Although the stock remains expensive, the fundamentals justify a premium for its unique positioning as a merchant supplier across over 130 high-growth defense programs.
What This Means for Me

Read More
Rocket Lab's Iridium Deal Gets a Boost from Strong Earnings
Neutral Iridium's Q3 earnings beat strengthens the case for Rocket Lab's $8 billion acquisition, potentially making RKLB profitable and cash-flow positive by 2027, but the stock's high valuation leaves little room for error.
IRDMRKLBOct 24, 2026SPCX Stock Jumps 7.8% on Q3 Earnings: Is It a Buy?
Bullish SpaceX's Q3 earnings beat, driven by explosive AI revenue growth, justifies a bullish stance for risk-tolerant investors, but the extreme valuation and Musk's history of overpromising warrant caution.
SPCXRKLBASTSTSLAOct 21, 2026Rocket Lab's Neutron Delay: What It Means for RKLB
Neutral The Neutron delay to 2027 is a significant setback that pushes back revenue growth, but Rocket Lab's strong backlog and small launch dominance provide a cushion.
RKLBOct 20, 2026

